All Articles Tagged With: "Epogen"
Articles
Side Effects of Aranesp, Procrit and Epogen Lead to New FDA Restrictions
Concerns over the increased risk of heart attacks, blood clots, tumors and death from side effects of Aranesp, Procrit and Epogen have led the FDA to restrict the prescribing of the anemia drugs under a risk evaluation and mitigation strategy (REMS).
Aranesp, Epogen and Procrit Health Risks to be Reviewed Further by FDA
The FDA indicates that it will further examine the side effects of anemia drugs, including Aranesp, Epogen and Procrit, due to the potential increased risk of heart attacks, strokes and blood clots.
Aranesp, Epogen and Procrit Blood Clot Risk Confirmed: Study
According to new research, the anti-anemia drugs Aranesp, Epogen and Procrit not only increase the risk of blood clots, but they also do not appear to be doing what they were designed to do.
Aranesp Increases Risk of Stroke for Some Patients: Study
New research suggests that side effects of Aranesp, an anemia drug, could increase the risk of stroke in some patients.
FDA Reviewing Epogen and Procrit Side Effects After Study Identifies Risk of Death
The FDA has issued an “Early Communication” about their ongoing safety review of a potential increased risk of death associated with Procrit and Epogen, which are used to treat anemia.
Epogen and Procrit Side Effects Linked to Death for Stroke Patients
Preliminary data from a study funded by Johnson & Johnson’s Ortho Biotech unit found that individuals who were given Procrit (which is also marketed as Epogen) following an ischemic stroke had a greater incidence of death than those who received a placebo.
